Munich Reinsurance Co Stock Corp in Munich Acquires New Position in Docusign Inc. $DOCU

Key Points

• Munich Reinsurance Co Stock Corp in Munich bought 244,327 shares of DocuSign in Q3, a new stake valued at about $17.6 million representing roughly 0.12% ownership.
• Insiders sold 77,476 shares (~$5.3 million) over the last quarter — including CRO Paula Hansen and Robert Chatwani — while institutional investors hold about 77.64% of the company.
• Several analysts have cut price targets recently (many into the $75–$82 range); the consensus rating is a Hold with an average price target of $78.80.

Munich Reinsurance Co Stock Corp in Munich acquired a new stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 244,327 shares of the company's stock, valued at approximately $17,614,000. Munich Reinsurance Co Stock Corp in Munich owned approximately 0.12% of Docusign at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Nordea Investment Management AB boosted its stake in Docusign by 3.6% in the third quarter. Nordea Investment Management AB now owns 1,154,824 shares of the company's stock valued at $87,316,000 after buying an additional 40,432 shares in the last quarter. Baird Financial Group Inc. raised its stake in Docusign by 927.2% during the second quarter. Baird Financial Group Inc. now owns 124,145 shares of the company's stock worth $9,670,000 after acquiring an additional 112,059 shares in the last quarter. Rakuten Investment Management Inc. bought a new position in shares of Docusign in the third quarter worth about $5,335,000. Bank of New York Mellon Corp lifted its holdings in shares of Docusign by 3.1% in the third quarter. Bank of New York Mellon Corp now owns 1,594,884 shares of the company's stock worth $114,975,000 after acquiring an additional 47,331 shares during the last quarter. Finally, Vise Technologies Inc. acquired a new stake in shares of Docusign in the 2nd quarter valued at approximately $436,000. Institutional investors and hedge funds own 77.64% of the company's stock.

Insider Buying and Selling

In related news, CRO Paula Hansen sold 6,000 shares of the business's stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total value of $402,300.00. Following the sale, the executive owned 68,970 shares of the company's stock, valued at $4,624,438.50. The trade was a 8.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Robert Chatwani sold 13,818 shares of the stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $68.33, for a total value of $944,183.94. Following the completion of the sale, the insider owned 70,197 shares of the company's stock, valued at $4,796,561.01. The trade was a 16.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 77,476 shares of company stock valued at $5,302,678 over the last quarter. 1.01% of the stock is currently owned by company insiders.

Docusign Stock Performance

Shares of NASDAQ DOCU opened at $48.69 on Friday. The firm has a 50 day moving average price of $53.84 and a two-hundred day moving average price of $65.84. The stock has a market cap of $9.75 billion, a P/E ratio of 34.05, a price-to-earnings-growth ratio of 2.10 and a beta of 1.03. Docusign Inc. has a 52-week low of $40.16 and a 52-week high of $94.67.

Wall Street Analyst Weigh In

DOCU has been the topic of several research reports. Evercore decreased their price target on shares of Docusign from $92.00 to $80.00 and set an "in-line" rating on the stock in a report on Friday, December 5th. Bank of America dropped their price objective on shares of Docusign from $102.00 to $82.00 and set a "neutral" rating for the company in a research note on Friday, December 5th. Robert W. Baird decreased their target price on shares of Docusign from $90.00 to $75.00 and set a "neutral" rating on the stock in a research note on Friday, December 5th. Zacks Research downgraded shares of Docusign from a "strong-buy" rating to a "hold" rating in a report on Monday, November 24th. Finally, UBS Group dropped their price target on Docusign from $85.00 to $75.00 and set a "neutral" rating for the company in a research note on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $78.80.

About Docusign

DocuSign, Inc NASDAQ: DOCU is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.